Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from Sequent Scientific Limited ( (IN:SEQUENT) ) is now available.
Sequent Scientific Limited and Viyash Lifesciences have received approval from the National Company Law Tribunal for their merger, marking a significant transformation in the global animal health market. The merger is expected to create a leading animal health powerhouse, leveraging combined strengths to enhance growth opportunities in the companion animal health segment and generic animal health products, while also boosting financial resilience and operational capabilities.
More about Sequent Scientific Limited
Sequent Scientific Limited is a prominent player in the global animal health industry, focusing on pharmaceuticals and life sciences. The company is known for its expertise in APIs and formulations, and it aims to capitalize on the growing companion animal health segment and the genericization of animal health products.
Average Trading Volume: 90,367
Technical Sentiment Signal: Buy
Current Market Cap: 57.53B INR
Find detailed analytics on SEQUENT stock on TipRanks’ Stock Analysis page.